Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2005
05/12/2005WO2005041944A2 Methods and compositions for promoting axon regeneration and cell replacement therapy
05/12/2005WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS
05/12/2005WO2005041874A2 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells
05/12/2005WO2005041859A2 Conjugates and compositions for cellular delivery.
05/12/2005WO2005041857A2 Bone morphogenetic protein (bmp) 2a and uses thereof
05/12/2005WO2005041750A2 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
05/12/2005WO2005041656A2 Methods, compositions and devices for inducing stasis in tissues and organs
05/12/2005WO2005041655A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
05/12/2005WO2005041649A1 Transgenic nonhuman mammal
05/12/2005WO2005041648A1 Hyperlipemia/ hyperalbuminemia model animal
05/12/2005WO2005029608A3 Probe solution, probe carrier, and method of manufacturing probe carrier
05/12/2005WO2005026364B1 Selection system containing non-antibiotic resistance selection marker
05/12/2005WO2005021777A3 Uses of spatial configuration to modulate protein function
05/12/2005WO2005019432A3 A novel gene and protein associated with angiogenesis and endothelial apoptosis
05/12/2005WO2005019424A3 Retroviral vector and cell-based assay for measuring the mutation rate of retroviruses employing same
05/12/2005WO2005019269A3 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
05/12/2005WO2005014829A3 Chemically-inducible promotors for the expression of proteis in plants
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005012515A8 Novel glyphosate-n-acetyltransferase (gat) genes
05/12/2005WO2005007699A3 Human antibody molecules for il-13
05/12/2005WO2005007072A3 Methods and pharmaceutical compositions for healing wounds
05/12/2005WO2005005662A3 Secreted proteins as markers for cell differentiation
05/12/2005WO2005003164A3 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
05/12/2005WO2004113566A3 Disease related protein network
05/12/2005WO2004113495A3 Rna-based transcriptional regulators
05/12/2005WO2004111240A3 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
05/12/2005WO2004111089A3 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
05/12/2005WO2004108938A3 Peptide ligands of dendritic cells for nucleic acid vector targeting
05/12/2005WO2004108260A3 Devices and methods for biomaterial production
05/12/2005WO2004094642A3 Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
05/12/2005WO2004092386A3 Inducing a t cell response with recombinant pestivirus replicons or recombinant pestivirus replicon-transfected dendritic cells
05/12/2005WO2004091572A3 Cochleate compositions directed against expression of proteins
05/12/2005WO2004090143A3 Modulation of cytokinin activity in plants
05/12/2005WO2004083441A3 Random peptide library displayed on aav vectors
05/12/2005WO2004081183A3 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
05/12/2005WO2004078124A3 Methods and compositions involving mda-7
05/12/2005WO2004077942A3 Inducible prostate cancer model
05/12/2005WO2004072233A3 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use
05/12/2005WO2004067560A3 Herpes simplex vp16 protein binding polypeptides
05/12/2005WO2004062351A3 Gene encoding resistance to acetolactate synthase-inhibiting herbicides
05/12/2005WO2004061083A3 Rna interference
05/12/2005WO2004055153A3 Devices coated with substances that mediate the adhesion of biological material
05/12/2005WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation
05/12/2005WO2004029284A3 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
05/12/2005WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals
05/12/2005WO2004018502A8 Compounds binding to p-selectin
05/12/2005WO2004007717A8 Proteomic screen to identify disease-related biological molecules and inhibitors thereto
05/12/2005WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/12/2005WO2003076601A8 Avian cell lines for the production of useful substances
05/12/2005WO2003076574A3 Targeted manipulation of genes in plants
05/12/2005WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
05/12/2005WO2003012056A3 Carotenoid ketolase gene
05/12/2005WO2002097031A3 Molecules for diagnostics and therapeutics
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102719 Sustained totipotent culture of selected monocot genera
05/12/2005US20050102717 Crop plant cystatin proteinase inhibitors and methods of use
05/12/2005US20050102716 Transgenic plants containing altered levels of sterol compounds and tocopherols
05/12/2005US20050102715 Disease resistance factors
05/12/2005US20050102714 hybrid cotton seeds and plants having male sterility, herbicide, insect and disease resistance; transgenic plants
05/12/2005US20050102713 Expression vector comprising regulatory sequences associated with expression of antifungal protein for use as tool in generating transgenic plants with enhanced exogeneous gene transcription and insect and herbicide resistance
05/12/2005US20050102712 Using chlorophyll biosynthesis enzyme as tool for identifying agents which enhance photosynthetic activity of plants
05/12/2005US20050102711 Expression vector comprising nucleotide sequences coding exogenous polypeptide for use in generation of disease, heat, freeze, herbicide and insect resistant plants
05/12/2005US20050102710 Cells comprising short anti-sense RNA sequences for use in treatment and prevention of cell proliferative, neurodegenerative and viral diseases
05/12/2005US20050102709 Short anti-sense RNA sequences for use in treatment and prevention of cell proliferative and viral diseases
05/12/2005US20050101774 Recombinant construct comprising a plurality of regulatory sequences for use as gene transfer tool for enhancing disease resistance, yield and flavor in plants
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101769 CD40-interacting and TRAF-interacting proteins
05/12/2005US20050101768 Nucleotide sequences coding hematopoietin receptor for use as tool in identifying modulators for treatment of cell proliferative disorders
05/12/2005US20050101767 Bacillus voltage-sensitive ion-selective transport protein for use in dientifying antagonist/agonist for prevention and treatment of cardiovascular disorders
05/12/2005US20050101762 Cyclic peptide for use as tool in transmembrane transport; drug delivery
05/12/2005US20050101559 Contacting tissues agents that increase vascular permeability to an exogenous nucleic acid followed by administering exogenous nucleic acid under a low calcium ion concentration; transfer efficiency is increased
05/12/2005US20050101558 Antisense modulation of PLML expression
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents
05/12/2005US20050101555 Antisense modulation of caspase 7 expression
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101553 Antisense modulation of calreticulin expression
05/12/2005US20050101552 Neurodegenerative disease; demyelination diseases; brain disorders; screening stem cells in brain; animal models; Alzheimer's, Parkinson's, Huntington's disease
05/12/2005US20050101536 Modulation of angiogenesis
05/12/2005US20050101530 Cellular virus receptors and methods of use
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101525 Method of complexing a nucleic acid with a lipid-conjugated polyamide
05/12/2005US20050101504 Microorganismal metalloproteases for use in textile treatment and as active agent in cleaning compounds and detergents; enhancement of nutritional quality of animal feeds
05/12/2005US20050101484 Method of imparting disease resistance to plants by reducing polyphenol oxidase activities
05/12/2005US20050101476 Synthesis of poly(ethylene amine) on an oxide support
05/12/2005US20050101020 Methods and products for delivering biological molecules to cells using multicomponent nanostructures
05/12/2005US20050101019 Method and device for targeted delivery of materials to selected single cells
05/12/2005US20050101018 Viral vector encoding pigment epithelium-derived factor
05/12/2005US20050101017 Using vector transformation to generate drug resistant embryonic stem cell; improving/enhancing heterologous gene expression
05/12/2005US20050101016 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders
05/12/2005US20050101015 Modification of plant metabolism
05/12/2005US20050101013 Antisense nucleotide sequences for modulating the expression of signal transducer and activator of transcription (STAT) proteins; cancer and tumor treatment; gene expression inhibition
05/12/2005US20050101004 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
05/12/2005US20050101001 Proteases from gram-position organisms
05/12/2005US20050101000 Modulation of phosphodiesterase 4B expression
05/12/2005US20050100999 Nucleic acid encoding receptor type protein kinase
05/12/2005US20050100998 Nucleotide sequences coding nucleotide monophosphate kinase for use as tool in identifying nucleoside analog which enhance antitumor drug efficacy
05/12/2005US20050100995 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity
05/12/2005US20050100987 Using ribonucleoside diphosphate reductase intein as tool to generate preferential amino terminal protein fusion; directed protein evolution
05/12/2005US20050100986 Compositions and methods for targeting a polypeptide to the central nervous system
1 ... 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 ... 4023